Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The disparity between supply and demand for organs has stimulated the development of strategies to increase the availability of kidney grafts. Such strategy involves the use of kidneys with expanded donor criteria (EDC). This is a study initiated by the investigator, open, prospective, randomized, single center designed to compare the safety and efficacy of two immunosuppressive regimens based on thymoglobulin, tacrolimus and everolimus versus thymoglobulin, tacrolimus and mycophenolate sodium in renal transplant recipients with donor criteria expanded.


Options:
A: Arm Label: Low-dose Everolimus Group; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Cyclosporine A (CsA), Drug: Basiliximab, Drug: Corticosteroids | Arm Label: High-dose Everolimus Group; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Cyclosporine A (CsA), Drug: Basiliximab, Drug: Corticosteroids | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mycophenolic Acid (MPA), Drug: Cyclosporine A (CsA), Drug: Basiliximab, Drug: Corticosteroids | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): High-dose Everolimus Group, Low-dose Everolimus Group | Intervention Type: DRUG; Name: Mycophenolic Acid (MPA); Assigned to Arm(s): Control Group | Intervention Type: DRUG; Name: Cyclosporine A (CsA); Assigned to Arm(s): Control Group, High-dose Everolimus Group, Low-dose Everolimus Group | Intervention Type: DRUG; Name: Basiliximab; Assigned to Arm(s): Control Group, High-dose Everolimus Group, Low-dose Everolimus Group | Intervention Type: DRUG; Name: Corticosteroids; Assigned to Arm(s): Control Group, High-dose Everolimus Group, Low-dose Everolimus Group
B: Arm Label: TAC+MPA; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus, Drug: Enteric Coated Mycophenolate Sodium (EC-MPS), Drug: Mycophenolate mofetil (MMF), Drug: Corticosteroids, Drug: Simulect | Arm Label: TAC+Certican; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Tacrolimus, Drug: Corticosteroids, Drug: Simulect | Arm Label: CycA+Certican; Type: EXPERIMENTAL; Interventions: Drug: Everolimus, Drug: Cyclosporin A, Drug: Corticosteroids, Drug: Simulect | Intervention Type: DRUG; Name: Everolimus; Assigned to Arm(s): CycA+Certican, TAC+Certican | Intervention Type: DRUG; Name: Tacrolimus; Assigned to Arm(s): TAC+Certican, TAC+MPA | Intervention Type: DRUG; Name: Cyclosporin A; Assigned to Arm(s): CycA+Certican | Intervention Type: DRUG; Name: Enteric Coated Mycophenolate Sodium (EC-MPS); Assigned to Arm(s): TAC+MPA | Intervention Type: DRUG; Name: Mycophenolate mofetil (MMF); Assigned to Arm(s): TAC+MPA | Intervention Type: DRUG; Name: Corticosteroids; Assigned to Arm(s): CycA+Certican, TAC+Certican, TAC+MPA | Intervention Type: DRUG; Name: Simulect; Assigned to Arm(s): CycA+Certican, TAC+Certican, TAC+MPA
C: Arm Label: EVR+rCNI; Type: EXPERIMENTAL; Interventions: Biological: Induction therapy, Drug: Corticosteroids, Drug: EVR+rCNI | Arm Label: MPA+sCNI; Type: ACTIVE_COMPARATOR; Interventions: Biological: Induction therapy, Drug: Corticosteroids, Drug: MPA+sCNI | Intervention Type: BIOLOGICAL; Name: Induction therapy; Assigned to Arm(s): EVR+rCNI, MPA+sCNI | Intervention Type: DRUG; Name: Corticosteroids; Assigned to Arm(s): EVR+rCNI, MPA+sCNI | Intervention Type: DRUG; Name: EVR+rCNI; Assigned to Arm(s): EVR+rCNI | Intervention Type: DRUG; Name: MPA+sCNI; Assigned to Arm(s): MPA+sCNI
D: Arm Label: Mycophenolate sodium; Type: ACTIVE_COMPARATOR; Interventions: Drug: Induction therapy with Thymoglobulin, prednisone, mycophenolate sodium and late introduction of tacrolimus | Arm Label: Everolimus; Type: EXPERIMENTAL; Interventions: Drug: Induction therapy with Thymoglobulin, prednisone, everolimus and late introduction of tacrolimus | Intervention Type: DRUG; Name: Induction therapy with Thymoglobulin, prednisone, everolimus and late introduction of tacrolimus; Assigned to Arm(s): Everolimus | Intervention Type: DRUG; Name: Induction therapy with Thymoglobulin, prednisone, mycophenolate sodium and late introduction of tacrolimus; Assigned to Arm(s): Mycophenolate sodium

Answer: D